'Hope to launch Covavax for adults in October, in early 2022 for kids': Adar Poonwalla
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Wednesday
February 01, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
WEDNESDAY, FEBRUARY 01, 2023
'Hope to launch Covavax for adults in October, in early 2022 for kids': Adar Poonwalla

Coronavirus chronicle

Hindustan Times
06 August, 2021, 07:40 pm
Last modified: 06 August, 2021, 07:46 pm

Related News

  • Ending the austerity pandemic
  • Asian shares head for worst month since pandemic started
  • Recovery in youth employment is still lagging: ILO
  • Indian vaccine giant Serum plans African plant in global expansion
  • India's Serum Institute applies for full approval of Covishield vaccine

'Hope to launch Covavax for adults in October, in early 2022 for kids': Adar Poonwalla

The Serum Institute of India CEO also said that the price of the anti-Covid vaccine will be determined at the time of launch

Hindustan Times
06 August, 2021, 07:40 pm
Last modified: 06 August, 2021, 07:46 pm
The Serum Institute was founded by Adar Poonawalla's father Cyrus Poonawalla in 1966 Photo: Reuters
The Serum Institute was founded by Adar Poonawalla's father Cyrus Poonawalla in 1966 Photo: Reuters

Serum Institute of India (SII) CEO Adar Poonawalla said on Friday he is "hopeful" that American pharmaceutical firm Novavax's vaccine candidate against the coronavirus disease (Covid-19), Covavax, will be launched in India for both adults and children in October and early 2022, respectively.

"I'm hopeful that for adults, Covavax, will be launched in October, depending upon approvals from the Drugs Controller General of India (DCGI). For kids, the Covavax vaccine will be launched in the first quarter of the next year, most likely in January-February," Poonawalla told news agency PTI, after meeting Union home minister Amit Shah in Parliament for 30 minutes.

Poonawalla's remarks, however, are in contradiction to earlier reports that claimed Covavax will be introduced in the country in September. Earlier, in a statement, Novavax had said the jab is 100% effective against moderate and severe Covid-19, with an overall efficacy of 90.4%.

Currently, every citizen aged 18 and above is eligible to be vaccinated against Covid-19. While a vaccine is yet to be approved for kids, Union health minister Mansukh Mandaviya said on July 27 that vaccination drive for children is likely to begin in August.

The Serum India CEO further said Covavax will be a two-dose vaccine and its price will be decided at the time of its launch. He also thanked prime minister Narendra Modi for his support. "The government is helping us and we are facing no financial crunch. We are thankful to PM Modi for all the cooperation and support," Poonawalla, who also met Mandaviya, said.

SII, which is the world's largest manufacturer of vaccines, is prominently involved in India's fight against the coronavirus pandemic. It is already manufacturing the Oxford University-AstraZeneca shot as Covishield locally, and will also manufacture Russia's Sputnik V vaccine, according to an agreement with the Russian Direct Investment Fund (RDIF).

Top News / South Asia

Covid-19 pandemic / Serum Institute of India / CEO Adar Poonawalla

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Will reform pledges to IMF work this time?
    Will reform pledges to IMF work this time?
  • Infographic: TBS
    How to redirect inward remittances to formal channels
  • Photo: TBS
    By-polls in BNP MPs' vacant seats: Few voters in B'baria polling centres, clash in Chapainawabganj

MOST VIEWED

  • People walk outside wearing masks during the coronavirus disease (COVID-19) pandemic in the Harlem area of the Manhattan borough of New York City, New York, U.S., February 10, 2022. REUTERS/Carlo Allegri
    US to end Covid-19 emergency declarations on 11 May
  • A nurse prepares a shot for Jonathan Halter as the German embassy begins its roll out of BioNTech COVID-19 vaccines for German expatriates at a Beijing United Family hospital in Beijing, China January 5, 2023. REUTERS/Thomas Peter/File Photo
    Covid remains a public health emergency, says WHO
  • FIKE PHOTO: Medical staff moves a patient into a fever clinic at a hospital, as coronavirus disease (COVID-19) outbreaks continue in Shanghai, China, December 19, 2022. REUTERS/Aly Song
    China approves two domestically developed Covid drugs
  • People walk with their luggage at a railway station during the annual Spring Festival travel rush ahead of the Chinese Lunar New Year, as the coronavirus disease (COVID-19) outbreak continues, in Shanghai, China January 16, 2023. REUTERS/Aly Song
    Holiday trips within China surge after lifting of Covid curbs
  • Photo: Collected
    India launches world’s 1st intranasal Covid vaccine
  • A vial of the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022. REUTERS/Hannah Beier
    US CDC still looking at potential stroke risk from Pfizer bivalent Covid shot

Related News

  • Ending the austerity pandemic
  • Asian shares head for worst month since pandemic started
  • Recovery in youth employment is still lagging: ILO
  • Indian vaccine giant Serum plans African plant in global expansion
  • India's Serum Institute applies for full approval of Covishield vaccine

Features

An elderly couple's lonely battle to save Dhaka's trees

An elderly couple's lonely battle to save Dhaka's trees

2h | Panorama
Infographic: TBS

How to redirect inward remittances to formal channels

4h | Panorama
Photo: Bloomberg

How the 'madoffs of Manhattan' can unravel Gautam Adani's empire

3h | Panorama
Photo: Collected

Tips to incorporate sustainable construction

1d | Habitat

More Videos from TBS

Alka Yagnik guinness world record

Alka Yagnik guinness world record

1h | TBS Entertainment
Interest rate should be left to market

Interest rate should be left to market

1h | TBS Round Table
Adani’s shares fell sharply after allegation

Adani’s shares fell sharply after allegation

17h | TBS World
Why Messi was blocked on Instagram?

Why Messi was blocked on Instagram?

16h | TBS SPORTS

Most Read

1
Bapex calls candidates for job test 9 years after advert!
Bangladesh

Bapex calls candidates for job test 9 years after advert!

2
Photo: Collected
Energy

8 Ctg power plants out of production

3
Photo: Saqlain Rizve
Bangladesh

Bangladeshi university students identified as problematic users of Facebook, internet: Study

4
Photo: Collected
Court

Japanese mother gets guardianship of daughters, free to leave country

5
Fund cut as Dhaka's fast-track transit projects on slow spending lane
Infrastructure

Fund cut as Dhaka's fast-track transit projects on slow spending lane

6
The International Monetary Fund (IMF) logo is seen outside the headquarters building in Washington, U.S., September 4, 2018. REUTERS/Yuri Gripas/File Photo
Economy

IMF approves $4.7 billion loan for Bangladesh, calls for ambitious reforms

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]